[
  {
    "ts": null,
    "headline": "Wasatch Global Value Fund Q4 2024 Commentary",
    "summary": "The Wasatch Global Value FundâInvestor Class returned -5.78% in the fourth quarter of 2024, underperforming the MSCI AC (All Country) World Value Index, which lost -4.71%.",
    "url": "https://finnhub.io/api/news?id=67f3c46cb50bbfc33d2c77e916080be8cf5a7974d16a0ef65a382ddb19b11760",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1742857560,
      "headline": "Wasatch Global Value Fund Q4 2024 Commentary",
      "id": 133359674,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1478940432/image_1478940432.jpg?io=getty-c-w1536",
      "related": "JNJ",
      "source": "SeekingAlpha",
      "summary": "The Wasatch Global Value FundâInvestor Class returned -5.78% in the fourth quarter of 2024, underperforming the MSCI AC (All Country) World Value Index, which lost -4.71%.",
      "url": "https://finnhub.io/api/news?id=67f3c46cb50bbfc33d2c77e916080be8cf5a7974d16a0ef65a382ddb19b11760"
    }
  },
  {
    "ts": null,
    "headline": "Johnson & Johnson (JNJ) Stock Dips While Market Gains: Key Facts",
    "summary": "The latest trading day saw Johnson & Johnson (JNJ) settling at $163.29, representing a -0.21% change from its previous close.",
    "url": "https://finnhub.io/api/news?id=4843fb2848dc902668d74f5147b9562838148e44d92aa8b7bd55266d50f1277e",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1742852717,
      "headline": "Johnson & Johnson (JNJ) Stock Dips While Market Gains: Key Facts",
      "id": 133360353,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JNJ",
      "source": "Yahoo",
      "summary": "The latest trading day saw Johnson & Johnson (JNJ) settling at $163.29, representing a -0.21% change from its previous close.",
      "url": "https://finnhub.io/api/news?id=4843fb2848dc902668d74f5147b9562838148e44d92aa8b7bd55266d50f1277e"
    }
  },
  {
    "ts": null,
    "headline": "ACIU Stock Crashes 18.3% in a Month: Buy, Sell or Hold?",
    "summary": "AC Immune's shares decline 18.3% in a month. While the company's pipeline progress is encouraging, we advise investors to remain on the sidelines for now.",
    "url": "https://finnhub.io/api/news?id=0a409d804aeaf45cebec460b6ca656c3ea42d6ca2b992f6051402256153b8f61",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1742842800,
      "headline": "ACIU Stock Crashes 18.3% in a Month: Buy, Sell or Hold?",
      "id": 133360354,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JNJ",
      "source": "Yahoo",
      "summary": "AC Immune's shares decline 18.3% in a month. While the company's pipeline progress is encouraging, we advise investors to remain on the sidelines for now.",
      "url": "https://finnhub.io/api/news?id=0a409d804aeaf45cebec460b6ca656c3ea42d6ca2b992f6051402256153b8f61"
    }
  },
  {
    "ts": null,
    "headline": "Argenx: The Magic May Be Already Priced In",
    "summary": "Argenx is a hold due to limited catalysts in 2025, a rich valuation and clinical risk around label expansion. Read more about ARGX stock here.",
    "url": "https://finnhub.io/api/news?id=0d2cee3752538f8b5993d1f1bf07d4f8c09a0f5d431d22d4713bb2b764bffc41",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1742824592,
      "headline": "Argenx: The Magic May Be Already Priced In",
      "id": 133352325,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2184219690/image_2184219690.jpg?io=getty-c-w1536",
      "related": "JNJ",
      "source": "SeekingAlpha",
      "summary": "Argenx is a hold due to limited catalysts in 2025, a rich valuation and clinical risk around label expansion. Read more about ARGX stock here.",
      "url": "https://finnhub.io/api/news?id=0d2cee3752538f8b5993d1f1bf07d4f8c09a0f5d431d22d4713bb2b764bffc41"
    }
  },
  {
    "ts": null,
    "headline": "Is Johnson & Johnson (JNJ) The Best Healthcare Dividend Stock to Invest in?",
    "summary": "We recently published a list of 13 Best Healthcare Dividend Stocks to Invest in. In this article, we are going to take a look at where Johnson & Johnson (NYSE:JNJ) stands against other best healthcare dividend stocks to invest in. The US healthcare sector has been at the forefront since the emergence of COVID-19 in […]",
    "url": "https://finnhub.io/api/news?id=2e696d75aa13938bebb71467a9fdd8322227b428ca9a26275ad8054f31541b77",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1742822082,
      "headline": "Is Johnson & Johnson (JNJ) The Best Healthcare Dividend Stock to Invest in?",
      "id": 133337819,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JNJ",
      "source": "Yahoo",
      "summary": "We recently published a list of 13 Best Healthcare Dividend Stocks to Invest in. In this article, we are going to take a look at where Johnson & Johnson (NYSE:JNJ) stands against other best healthcare dividend stocks to invest in. The US healthcare sector has been at the forefront since the emergence of COVID-19 in […]",
      "url": "https://finnhub.io/api/news?id=2e696d75aa13938bebb71467a9fdd8322227b428ca9a26275ad8054f31541b77"
    }
  },
  {
    "ts": null,
    "headline": "Take the Zacks Approach to Beat the Markets: CMS Energy, Chevron, AutoZone in Focus",
    "summary": "Last week, our time-tested methodologies served investors well in navigating the market. Check out some of our achievements from the past three months.",
    "url": "https://finnhub.io/api/news?id=7909623f72a1837578f582d4210640507aa2af6078455167726b2d2ac5a65fbd",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1742819940,
      "headline": "Take the Zacks Approach to Beat the Markets: CMS Energy, Chevron, AutoZone in Focus",
      "id": 133337820,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JNJ",
      "source": "Yahoo",
      "summary": "Last week, our time-tested methodologies served investors well in navigating the market. Check out some of our achievements from the past three months.",
      "url": "https://finnhub.io/api/news?id=7909623f72a1837578f582d4210640507aa2af6078455167726b2d2ac5a65fbd"
    }
  },
  {
    "ts": null,
    "headline": "Johnson & Johnson to break ground on new state-of-the-art biologics facility in North Carolina to deliver market-leading portfolio of transformational therapies",
    "summary": "New Brunswick, N.J., - Johnson & Johnson today will break ground on its new, 500,000 square foot, state-of-the-art biologics manufacturing facility in Wilson, North Carolina, which will expand its...",
    "url": "https://finnhub.io/api/news?id=0867ef4ef9900fdd7db19f4baa6d1d9268a7795f55f70a3f8de986f6ce662064",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1742816842,
      "headline": "Johnson & Johnson to break ground on new state-of-the-art biologics facility in North Carolina to deliver market-leading portfolio of transformational therapies",
      "id": 133343158,
      "image": "",
      "related": "JNJ",
      "source": "Finnhub",
      "summary": "New Brunswick, N.J., - Johnson & Johnson today will break ground on its new, 500,000 square foot, state-of-the-art biologics manufacturing facility in Wilson, North Carolina, which will expand its...",
      "url": "https://finnhub.io/api/news?id=0867ef4ef9900fdd7db19f4baa6d1d9268a7795f55f70a3f8de986f6ce662064"
    }
  },
  {
    "ts": null,
    "headline": "Here's How to Play JNJ Stock as it Announces $55B US Investment Plan",
    "summary": "Those who own JNJ stock may stay invested for some time, as the company is optimistic about a better performance in 2025.",
    "url": "https://finnhub.io/api/news?id=fa38c08ed5c3217cac59e1e77f74164bbde6f03c3e3f2ba07a50bdd355732748",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1742812260,
      "headline": "Here's How to Play JNJ Stock as it Announces $55B US Investment Plan",
      "id": 133337821,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JNJ",
      "source": "Yahoo",
      "summary": "Those who own JNJ stock may stay invested for some time, as the company is optimistic about a better performance in 2025.",
      "url": "https://finnhub.io/api/news?id=fa38c08ed5c3217cac59e1e77f74164bbde6f03c3e3f2ba07a50bdd355732748"
    }
  },
  {
    "ts": null,
    "headline": "Spinoffs Can Pay Juicy Dividends. 6 Ones to Play.",
    "summary": "Spinoffs Can Pay Juicy Dividends. 6 Ones to Play.",
    "url": "https://finnhub.io/api/news?id=6027893ec93c8538b3cd2acaf99ad07b6cbb94e6776e950cf01aca097c1451d3",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1721831400,
      "headline": "Spinoffs Can Pay Juicy Dividends. 6 Ones to Play.",
      "id": 131049981,
      "image": "",
      "related": "JNJ",
      "source": "MarketWatch",
      "summary": "Spinoffs Can Pay Juicy Dividends. 6 Ones to Play.",
      "url": "https://finnhub.io/api/news?id=6027893ec93c8538b3cd2acaf99ad07b6cbb94e6776e950cf01aca097c1451d3"
    }
  },
  {
    "ts": null,
    "headline": "Johnson & Johnson Increases U.S. Investment to More than $55 Billion over the Next Four Years",
    "summary": "NEW BRUNSWICK - Johnson & Johnson , healthcare's leading, most comprehensive innovation powerhouse, announced manufacturing, research and development, and technology investments of more than $55...",
    "url": "https://finnhub.io/api/news?id=fea6899b6299ac512bc946b66fc0716d639d80f0c511a2dc7f9b244aa6ca17ab",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1742794345,
      "headline": "Johnson & Johnson Increases U.S. Investment to More than $55 Billion over the Next Four Years",
      "id": 133335606,
      "image": "",
      "related": "JNJ",
      "source": "Finnhub",
      "summary": "NEW BRUNSWICK - Johnson & Johnson , healthcare's leading, most comprehensive innovation powerhouse, announced manufacturing, research and development, and technology investments of more than $55...",
      "url": "https://finnhub.io/api/news?id=fea6899b6299ac512bc946b66fc0716d639d80f0c511a2dc7f9b244aa6ca17ab"
    }
  }
]